Katherine T. Bagnowski

Katherine T. Bagnowski

Auto-generated profile, based on publicly available information

Katherine T. Bagnowski

Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
HLHaoming Liu
Haoming Liu
RKRichard S. Kang
Richard S. Kang
KBKatherine Bagnowski
Katherine Bagnowski
JYJeong Min Yu
Jeong Min Yu
SRSara Radecki
Sara Radecki
Amy PallerAmy Paller
Amy Paller

28 April 2022 in JID Innovations
Verified
Journal Article
Open access
MHMadeline J. Hooper
Madeline J. Hooper
TLTessa M. LeWitt
Tessa M. LeWitt
FVFrancesca L. Veon
Francesca L. Veon
YPYanzhen Pang
Yanzhen Pang
GCGeorge E. Chlipala
George E. Chlipala
XZXiaolong A. Zhou
Xiaolong A. Zhou
The nasal microbiome of patients with cutaneous T-cell lymphoma (CTCL) remains unexplored despite growing evidence connecting nasal bacteria to skin health and disease. Nasal swabs from 45 patients with CTCL (40 with mycosis fungoides, 5 with Sézary syndrome) and 20 healthy controls from the same geographical region (Chicago Metropolitan Area, Chicago, IL) were analyzed using sequencing of 16S ribosomal RNA and tuf2 gene amplicons. Nasal α-diversity did not differ between mycosis fungoides/Sézary syndrome and healthy controls (Shannon index, genus level, P = 0.201), but distinct microbial communities were identified at the class (R2 = 0.104, P = 0.023) and order (R2 = 0.0904, P = 0.038) levels. Increased relative abundance of the genera Catenococcus, Vibrio, Roseomonas, Acinetobacter, and unclassified Clostridiales was associated with increased skin disease burden (P < 0.005, q < 0.05). Performed to accurately resolve nasal Staphylococcus at the species level, tuf2 gene amplicon sequencing revealed no significant differences between mycosis fungoides/Sézary syndrome and healthy controls. Although S. aureus has been shown to worsen CTCL through its toxins, no increase in the relative abundance of this taxon was observed in nasal samples. Despite the lack of differences in Staphylococcus, the CTCL nasal microbiome was characterized by shifts in numerous other bacterial taxa. These data add to our understanding of the greater CTCL microbiome and provide context for comprehending nasal-skin and host‒tumor‒microbial relationships.